I have Type 1 diabetes. I love to write. I’m happy when I am helping others. I speak up when it’s important. I have a passion for sharing knowledge and learning new technology. I was BORN to BLOG!

I’ve met so many other T1Ds on this journey who are cool and love to help others. We put our heads and hearts together … to bring more resources and knowledge to our amazing diabetes community. We’re making improvements every day … come back often, let us know what you think. And my gratitude for my amazing webmaster, Dave (an honorary T1D)!

And thank you for stopping by!
— Joanne Laufer Milo, The Savvy Diabetic

Savvy Updates, 10/17/22:  Dexcom G7 Global Rollout, T2D Drugs Help T1Ds, BefA Gut Bacteria & Beta Cell Production, FDA TAP Pilot Program for New D Devices

Savvy Updates, 10/17/22: Dexcom G7 Global Rollout, T2D Drugs Help T1Ds, BefA Gut Bacteria & Beta Cell Production, FDA TAP Pilot Program for New D Devices

Dexcom Announces Global Rollout of G7, as reported by Andrew Briskin for diaTribe.org, 10 October 2022. Dexcom, one of the leading manufacturers of CGM, announced on Oct. 4 that its latest product, the Dexcom G7, is now available for people with diabetes, ages 2...

read more
Savvy Updates, 9/26/22:  Medtronic Pumps & Cybersecurity Risk, Diabeloop Algorithm Increases TIR, T1D & UTIs, Moderate Diabetes Distress Even with CGM

Savvy Updates, 9/26/22: Medtronic Pumps & Cybersecurity Risk, Diabeloop Algorithm Increases TIR, T1D & UTIs, Moderate Diabetes Distress Even with CGM

FDA Warns of Cybersecurity Risk With Medtronic MiniMed 600 Series Insulin Pumps was reported by David Kerr, MD, for Healio.com/endocrinology, 20 September 2022. The FDA has issued an alert warning people with diabetes using a Medtronic MiniMed 630G or MiniMed 670G...

read more
Savvy Updates, 9/19/22:  Investor Lawsuit against Medtronic, Synthetic Human Gut Microbiome, Sex of Researcher Affects Study Outcomes, Loss of “Caring” in Healthcare

Savvy Updates, 9/19/22: Investor Lawsuit against Medtronic, Synthetic Human Gut Microbiome, Sex of Researcher Affects Study Outcomes, Loss of “Caring” in Healthcare

Investor lawsuit accuses Medtronic of failing to disclose insulin pump problems was posted by Mick Paul Taylor for MedTechDive.com, 13 September 2022.   Investors have accused Medtronic of failing to disclose problems with its insulin pump business that...

read more
Savvy Updates 9/12/22:  Novo saves Zegalogue, Sugar Disrupts Microbiome, Cravings for Fatty Foods, DPAC Sues HHS for Copay Accumulators, Best Places for Dexcom G6 Sensor

Savvy Updates 9/12/22: Novo saves Zegalogue, Sugar Disrupts Microbiome, Cravings for Fatty Foods, DPAC Sues HHS for Copay Accumulators, Best Places for Dexcom G6 Sensor

Zealand summons Novo Nordisk to resuscitate floundering diabetes newcomer Zegalogue was reported by Fraiser Kansteiner for FiercePharma.com, 7 September 2022. Zealand said it has forged a global license and development pact with Novo Nordisk to take the marketing...

read more
Savvy Updates, 9/6/22: Senseonics CFO Leaves, Beta Bionics Trial Data & RIF, Chip-free, Wireless Electronic Skin, Insulin Pill, Cognitive Benefits from Hybrid Closed Loop Systems, Sugar & Microbiome, T1D & Hypothyroidism

Savvy Updates, 9/6/22: Senseonics CFO Leaves, Beta Bionics Trial Data & RIF, Chip-free, Wireless Electronic Skin, Insulin Pill, Cognitive Benefits from Hybrid Closed Loop Systems, Sugar & Microbiome, T1D & Hypothyroidism

Senseonics Announces CFO Transition was published by Senseonics Holdings, Inc., 1 September 2022.   Senseonics, a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems...

read more
Share This
Skip to content